Works matching AU Bendriss-Vermare, Nathalie


Results: 31
    1

    Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58220-8
    By:
    • Sakref, Candice;
    • Saby, Alexis;
    • Rodriguez, Céline;
    • Ardin, Maude;
    • Moudombi, Lyvia;
    • Doffin, Anne-Claire;
    • Gobbini, Elisa;
    • Voissiere, Aurélien;
    • Besson, Laurie;
    • Laoubi, Léo;
    • Böttcher, Jan;
    • Depil, Stéphane;
    • Hubert, Margaux;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Valladeau-Guilemond, Jenny
    Publication type:
    Article
    2
    3
    4
    5

    Type 1 conventional dendritic cells and interferons are required for spontaneous CD4<sup>+</sup> and CD8<sup>+</sup> T‐cell protective responses to breast cancer.

    Published in:
    Clinical & Translational Immunology, 2021, v. 10, n. 7, p. 1, doi. 10.1002/cti2.1305
    By:
    • Mattiuz, Raphaël;
    • Brousse, Carine;
    • Ambrosini, Marc;
    • Cancel, Jean‐Charles;
    • Bessou, Gilles;
    • Mussard, Julie;
    • Sanlaville, Amélien;
    • Caux, Christophe;
    • Bendriss‐Vermare, Nathalie;
    • Valladeau‐Guilemond, Jenny;
    • Dalod, Marc;
    • Crozat, Karine
    Publication type:
    Article
    6

    Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs.

    Published in:
    Clinical & Translational Immunology, 2020, v. 9, n. 12, p. 1, doi. 10.1002/cti2.1208
    By:
    • Ouaguia, Laurissa;
    • Dufeu‐Duchesne, Tania;
    • Leroy, Vincent;
    • Decaens, Thomas;
    • Reiser, Jean‐Baptiste;
    • Sosa Cuevas, Eleonora;
    • Durantel, David;
    • Valladeau‐Guilemond, Jenny;
    • Bendriss‐Vermare, Nathalie;
    • Chaperot, Laurence;
    • Aspord, Caroline
    Publication type:
    Article
    7
    8

    CD163<sup>+</sup> tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes.

    Published in:
    Clinical & Translational Immunology, 2020, v. 9, n. 2, p. 1, doi. 10.1002/cti2.1108
    By:
    • Ramos, Rodrigo Nalio;
    • Rodriguez, Céline;
    • Hubert, Margaux;
    • Ardin, Maude;
    • Treilleux, Isabelle;
    • Ries, Carola H;
    • Lavergne, Emilie;
    • Chabaud, Sylvie;
    • Colombe, Amélie;
    • Trédan, Olivier;
    • Guedes, Henrique Gomes;
    • Laginha, Fábio;
    • Richer, Wilfrid;
    • Piaggio, Eliane;
    • Barbuto, José Alexandre M;
    • Caux, Christophe;
    • Ménétrier‐Caux, Christine;
    • Bendriss‐Vermare, Nathalie
    Publication type:
    Article
    9

    Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.

    Published in:
    OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2372118
    By:
    • Dalle, Stéphane;
    • Verronese, Estelle;
    • N'Kodia, Axelle;
    • Bardin, Christine;
    • Rodriguez, Céline;
    • Andrieu, Thibault;
    • Eberhardt, Anais;
    • Chemin, Gabriel;
    • Hasan, Uzma;
    • Le-Bouar, Myrtille;
    • Caramel, Julie;
    • Amini-Adle, Mona;
    • Bendriss-Vermare, Nathalie;
    • Dubois, Bertrand;
    • Caux, Christophe;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    10

    Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.

    Published in:
    OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.1944554
    By:
    • Bouaoud, Jebrane;
    • Foy, Jean-Philippe;
    • Tortereau, Antonin;
    • Michon, Lucas;
    • Lavergne, Vincent;
    • Gadot, Nicolas;
    • Boyault, Sandrine;
    • Valantin, Julie;
    • De Souza, Geneviève;
    • Zrounba, Philippe;
    • Bertolus, Chloé;
    • Bendriss-Vermare, Nathalie;
    • Saintigny, Pierre
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Breast carcinoma cells promote the differentiation of CD34.

    Published in:
    International Journal of Cancer, 2004, v. 110, n. 5, p. 710, doi. 10.1002/ijc.20146
    By:
    • Thomachot, Marie Cécile;
    • Bendriss-Vermare, Nathalie;
    • Massacrier, Catherine;
    • Biota, Cathy;
    • Treilleux, Isabelle;
    • Goddard, Sophie;
    • Caux, Christophe;
    • Bachelot, Thomas;
    • Blay, Jean Yves;
    • Menetrier-Caux, Christine
    Publication type:
    Article
    17
    18
    19

    Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.

    Published in:
    International Journal of Cancer, 2013, v. 133, n. 3, p. 771, doi. 10.1002/ijc.28072
    By:
    • Sisirak, Vanja;
    • Vey, Nelly;
    • Goutagny, Nadège;
    • Renaudineau, Sarah;
    • Malfroy, Marine;
    • Thys, Sandra;
    • Treilleux, Isabelle;
    • Labidi‐Galy, Sana Intidhar;
    • Bachelot, Thomas;
    • Dezutter‐Dambuyant, Colette;
    • Ménétrier‐Caux, Christine;
    • Blay, Jean‐Yves;
    • Caux, Christophe;
    • Bendriss‐Vermare, Nathalie
    Publication type:
    Article
    20

    Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

    Published in:
    Acta Neuropathologica, 2018, v. 135, n. 4, p. 569, doi. 10.1007/s00401-017-1802-y
    By:
    • Small, Mathilde;
    • Treilleux, Isabelle;
    • Couillault, Coline;
    • Pissaloux, Daniel;
    • Picard, Géraldine;
    • Paindavoine, Sandrine;
    • Attignon, Valery;
    • Wang, Qing;
    • Rogemond, Véronique;
    • Lay, Stéphanie;
    • Ray-Coquard, Isabelle;
    • Pfsterer, Jacobus;
    • Joly, Florence;
    • Du Bois, Andreas;
    • Psimaras, Dimitri;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Honnorat, Jérôme;
    • Desestret, Virginie
    Publication type:
    Article
    21
    22
    23
    24

    Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

    Published in:
    BMC Cancer, 2011, v. 11, n. 1, p. 213, doi. 10.1186/1471-2407-11-213
    By:
    • Cassier, Philippe A.;
    • Treilleux, Isabelle;
    • Bachelot, Thomas;
    • Ray-Coquard, Isabelle;
    • Bendriss-Vermare, Nathalie;
    • Ménétrier-Caux, Christine;
    • Trédan, Olivier;
    • Goddard-Léon, Sophie;
    • Pin, Jean-Jacques;
    • Mignotte, Hervé;
    • Bathélémy-Dubois, Clarisse;
    • Caux, Christophe;
    • Lebecque, Serge;
    • Blay, Jean-Yves
    Publication type:
    Article
    25

    IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.

    Published in:
    Science Immunology, 2020, v. 5, n. 46, p. 1, doi. 10.1126/sciimmunol.aav3942
    By:
    • Hubert, Margaux;
    • Gobbini, Elisa;
    • Couillault, Coline;
    • Manh, Thien-Phong Vu;
    • Doffin, Anne-Claire;
    • Berthet, Justine;
    • Rodriguez, Céline;
    • Ollion, Vincent;
    • Kielbassa, Janice;
    • Sajous, Christophe;
    • Treilleux, Isabelle;
    • Tredan, Olivier;
    • Dubois, Bertrand;
    • Dalod, Marc;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Valladeau-Guilemond, Jenny
    Publication type:
    Article
    26
    27

    Durable and controlled depletion of neutrophils in mice.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16596-9
    By:
    • Boivin, Gael;
    • Faget, Julien;
    • Ancey, Pierre-Benoit;
    • Gkasti, Aspasia;
    • Mussard, Julie;
    • Engblom, Camilla;
    • Pfirschke, Christina;
    • Contat, Caroline;
    • Pascual, Justine;
    • Vazquez, Jessica;
    • Bendriss-Vermare, Nathalie;
    • Caux, Christophe;
    • Vozenin, Marie-Catherine;
    • Pittet, Mikael J.;
    • Gunzer, Matthias;
    • Meylan, Etienne
    Publication type:
    Article
    28

    Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts.

    Published in:
    PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009741
    By:
    • David, Marion;
    • Wannecq, Estelle;
    • Descotes, Françoise;
    • Jansen, Silvia;
    • Deux, Blandine;
    • Ribeiro, Johnny;
    • Serre, Claire-Marie;
    • Grès, Sandra;
    • Bendriss-Vermare, Nathalie;
    • Bollen, Mathieu;
    • Saez, Simone;
    • Aoki, Junken;
    • Saulnier-Blache, Jean-Sé bastien;
    • Clézardin, Philippe;
    • Peyruchaud, Olivier
    Publication type:
    Article
    29

    The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 731, p. 1, doi. 10.1126/scitranslmed.add1834
    By:
    • Voissière, Aurélien;
    • Gomez-Roca, Carlos;
    • Chabaud, Sylvie;
    • Rodriguez, Céline;
    • Nkodia, Axelle;
    • Berthet, Justine;
    • Montane, Laure;
    • Bidaux, Anne-Sophie;
    • Treilleux, Isabelle;
    • Eberst, Lauriane;
    • Terret, Catherine;
    • Korakis, Iphigénie;
    • Garin, Gwenaelle;
    • Pérol, David;
    • Delord, Jean-Pierre;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Ménétrier-Caux, Christine;
    • Bendriss-Vermare, Nathalie;
    • Cassier, Philippe A.
    Publication type:
    Article
    30
    31